93 related articles for article (PubMed ID: 1455369)
21. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
22. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
[TBL] [Abstract][Full Text] [Related]
23. Strong association of autoantibodies to human nuclear lamin B1 with lupus anticoagulant antibodies in systemic lupus erythematosus.
Senécal JL; Rauch J; Grodzicky T; Raynauld JP; Uthman I; Nava A; Guimond M; Raymond Y
Arthritis Rheum; 1999 Jul; 42(7):1347-53. PubMed ID: 10403261
[TBL] [Abstract][Full Text] [Related]
24. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
26. [The role of hyperhomocysteinemia in systemic lupus erythematosus and antiphospholipid syndrome].
Reshetniak TM; Shirokova IE; Lisitskaia TL
Ter Arkh; 2006; 78(6):24-30. PubMed ID: 16881359
[TBL] [Abstract][Full Text] [Related]
27. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
28. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.
Afeltra A; Vadacca M; Conti L; Galluzzo S; Mitterhofer AP; Ferri GM; Del Porto F; Caccavo D; Gandolfo GM; Amoroso A
Arthritis Rheum; 2005 Jun; 53(3):452-9. PubMed ID: 15934123
[TBL] [Abstract][Full Text] [Related]
29. VH4-34 encoded antibody in systemic lupus erythematosus: effect of isotype.
Bhat NM; Lee LM; van Vollenhoven RF; Teng NN; Bieber MM
J Rheumatol; 2002 Oct; 29(10):2114-21. PubMed ID: 12375320
[TBL] [Abstract][Full Text] [Related]
30. Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus.
Weidmann CE; Wallace DJ; Peter JB; Knight PJ; Bear MB; Klinenberg JR
J Rheumatol; 1988 Jan; 15(1):74-9. PubMed ID: 3351842
[TBL] [Abstract][Full Text] [Related]
31. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
[TBL] [Abstract][Full Text] [Related]
32. Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses.
Sanmarco M; Alessi MC; Harle JR; Sapin C; Aillaud MF; Gentile S; Juhan-Vague I; Weiller PJ
Thromb Haemost; 2001 May; 85(5):800-5. PubMed ID: 11372671
[TBL] [Abstract][Full Text] [Related]
33. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
34. Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE.
Sebastiani GD; Galeazzi M; Tincani A; Piette JC; Font J; Allegri F; Mathieu A; Smolen J; de Ramon Garrido E; Fernandez-Nebro A; Jedryka-Goral A; Papasteriades C; Morozzi G; Bellisai F; De Pitá O; Marcolongo R
Scand J Rheumatol; 1999; 28(6):344-51. PubMed ID: 10665739
[TBL] [Abstract][Full Text] [Related]
35. Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Khamashta MA; Amengual O; Hughes GR
J Rheumatol; 1998 Jun; 25(6):1104-8. PubMed ID: 9632071
[TBL] [Abstract][Full Text] [Related]
36. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
37. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome].
Reshetniak TM; Derksen RV; Alekberova ZS; Horbach D; De Groot F; Nasonov EL; Kalashnikova LA; Match ES; Nasonova VA
Klin Med (Mosk); 1998; 76(3):36-40. PubMed ID: 9575746
[TBL] [Abstract][Full Text] [Related]
38. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
[TBL] [Abstract][Full Text] [Related]
39. Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome.
Sipek-Dolnicar A; Hojnik M; Rozman B; Vizjak A; Ferluga D
Wien Klin Wochenschr; 2000 Aug; 112(15-16):707-10. PubMed ID: 11020961
[TBL] [Abstract][Full Text] [Related]
40. Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus.
López-Longo FJ; Monteagudo I; González CM; Moreno AC; Rodríguez Mahou M; Grau R; Carreño L
J Rheumatol; 1998 Sep; 25(9):1743-9. PubMed ID: 9733455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
